New Year’s Hangover: Neumora’s Phase III Failure In Depression Surprises

 
• By Joseph Haas

Neumora, one of two firms testing kappa opioid receptor antagonism in depression, failed its first of three Phase III studies. The company’s share price crashed sharply.

depressed Women sitting head in hands on the bed in the dark bedroom with low light environment, dramatic concept
Neumora fails a Phase III study with its novel MDD candidate • Source: Shutterstock

More from Start-Ups & SMEs

More from Therapy Areas